Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1

Conditions

Myelodysplastic Syndromes 97Leukemia 72Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia, Lymphocytic, Chronic, B-Cell 52Lymphoma 48Myeloproliferative Disorders 47Lymphoma, Non-Hodgkin 46Leukemia, Myeloid, Chronic-Phase 44Hodgkin Disease 44Multiple Myeloma 43Leukemia, Myeloid, Accelerated Phase 41Lymphoma, Follicular 39Lymphoma, Mantle-Cell 38Lymphoma, B-Cell, Marginal Zone 37Burkitt Lymphoma 37Lymphoma, Large B-Cell, Diffuse 36Congenital Abnormalities 34Neoplasms, Plasma Cell 33Lymphoma, Large-Cell, Immunoblastic 32Blast Crisis 31Leukemia, Myelomonocytic, Chronic 30Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 28Dendritic Cell Sarcoma, Interdigitating 27Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Recurrence 23Graft vs Host Disease 23

Interventions

fludarabine 6Cyclophosphamide 6fludarabine phosphate 5Whole-Body Irradiation 5Mycophenolic Acid 4Tacrolimus 2Sirolimus 2Antilymphocyte Serum 2Allopurinol 2itacitinib 1Peripheral Blood Stem Cell Transplantation 1Hematopoietic Stem Cell Transplantation 1Cyclosporine 1Association 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Plasma Cell × Antilymphocyte Serum × Myeloid × Clear all
NCT02722668 2025-07-04

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
15 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Plasma Cell, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT02661035 2023-09-21

Allo HSCT Using RIC for Hematological Diseases

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
156 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hematologic Diseases, Leukemia, Plasma Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡